Detailed answers about NEXTGENONCOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was NEXTGENONCOLOGY LIMITED founded?
NEXTGENONCOLOGY LIMITED was officially incorporated on 5 May 2022 and is registered under company number 14087498. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEXTGENONCOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEXTGENONCOLOGY LIMITED?
NEXTGENONCOLOGY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEXTGENONCOLOGY LIMITED do?
NEXTGENONCOLOGY LIMITED operates in the following sectors: 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is NEXTGENONCOLOGY LIMITED's registered address?
The registered office address of NEXTGENONCOLOGY LIMITED is 43A HIGH STREET, BARKINGSIDE, ESSEX, ENGLAND, IG6 2AD. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEXTGENONCOLOGY LIMITED financially stable?
The most recent accounts for NEXTGENONCOLOGY LIMITED were made up to 30 April 2025, filed as MICRO ENTITY. Next accounts are due by 31 January 2027.